Health
Eli Lilly Pushes Employers to Cover GLP-1 Drugs
Eli Lilly launches a program to make it easier for employers to add GLP-1 weight loss and diabetes drugs to their health plans, addressing a major coverage gap.
Key Takeaways
- Eli Lilly offers employers outcome-based contracts for GLP-1 drug coverage
- Over 40% of US adults meet clinical criteria for obesity treatment
- Program includes negotiated pricing tiers and workplace wellness integration
- Competitive move against Novo Nordisk's dominant Ozempic and Wegovy
DE
DT Editorial AI··via endpoints.news